| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL SCIENCE: Clinical Dialysis |
1
*Division of Nephrology, University of Texas Health Science Center, San Antonio, Texas ||Research and Development Service, South Texas Veterans Health Care System, Audie L. Murphy Division, San Antonio, Texas
2
Renal Unit, Massachusetts General Hospital, Boston, Massachusetts
3
Division of Research, Kaiser Permanente of Northern California, Oakland, California; and
Departments of Epidemiology, Biostatistics, and Medicine, University of California, San Francisco, California
4
* To whom correspondence should be addressed. E-mail: ayus{at}uthscsa.edu.
| Abstract |
|---|
Left ventricular hypertrophy (LVH) and inflammation independently increase risk for death in people who receive hemodialysis. A nonrandomized, controlled trial was conducted of the effect of short daily (6 sessions/wk of 3 h each) or conventional (three sessions/wk of 4 h each) hemodialysis on LVH and inflammatory factors. A total of 26 short daily hemodialysis and 51 matched conventional hemodialysis patients were enrolled, and baseline and 12-mo measures of echocardiographic left ventricular mass index (LVMI), serum C-reactive protein (CRP), serum calcium and phosphorus, and erythropoietin resistance index were collected. Baseline characteristics were similar between groups except that hemoglobin and serum calcium were lower and serum phosphorus was higher in the short daily hemodialysis group. At 12-mo follow-up, short daily hemodialysis patients experienced a 30% decrease in LVMI (154 ± 33 to 108 ± 25; P < 0.0001). After adjustment for potential confounders, short daily hemodialysis (
= -41.63, P = 0.03) and percentage decrease in serum phosphorus (
= -0.12, P = 0.04) predicted a 12-mo decrease in LVMI. Among short daily hemodialysis patients, there were significant reductions in median CRP levels (1.22 [95% confidence interval (CI) 0.37 to 3.70] to 0.05 [95% CI 0.05 to 1.17]; P < 0.01) and erythropoietin resistance index (19.5 [95% CI 8.6 to 37.6] to 10.5 [95% CI 5.5 to 14.6]; P < 0.001). There were no significant changes in LVMI, CRP, or erythropoietin resistance index in the conventional hemodialysis group. Short daily hemodialysis is associated with improved fluid and phosphorus management and a reduction in LVH and inflammatory factors compared with conventional hemodialysis. Future trials are needed to determine whether short daily hemodialysis can reduce morbidity and mortality in this high-risk population.
This article has been cited by other articles:
![]() |
R. Pellicano, B. J. Strauss, K. R. Polkinghorne, and P. G. Kerr Body composition in home haemodialysis versus conventional haemodialysis: a cross-sectional, matched, comparative study Nephrol. Dial. Transplant., February 1, 2010; 25(2): 568 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Valdivielso, J. Cannata-Andia, B. Coll, and E. Fernandez A new role for vitamin D receptor activation in chronic kidney disease Am J Physiol Renal Physiol, December 1, 2009; 297(6): F1502 - F1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Kaysen Biochemistry and Biomarkers of Inflamed Patients: Why Look, What to Assess Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S56 - S63. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Glassock, R. Pecoits-Filho, and S. H. Barberato Left Ventricular Mass in Chronic Kidney Disease and ESRD Clin. J. Am. Soc. Nephrol., December 1, 2009; 4(Supplement_1): S79 - S91. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Gutierrez, J. L. Januzzi, T. Isakova, K. Laliberte, K. Smith, G. Collerone, A. Sarwar, U. Hoffmann, E. Coglianese, R. Christenson, et al. Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease Circulation, May 19, 2009; 119(19): 2545 - 2552. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Isakova, O. M. Gutierrez, Y. Chang, A. Shah, H. Tamez, K. Smith, R. Thadhani, and M. Wolf Phosphorus Binders and Survival on Hemodialysis J. Am. Soc. Nephrol., February 1, 2009; 20(2): 388 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Power, N Duncan, and C Goodlad Advances and innovations in dialysis in the 21st century Postgrad. Med. J., February 1, 2009; 85(1000): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. M. de Francisco, P. Stenvinkel, and S. Vaulont Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness NDT Plus, January 1, 2009; 2(suppl_1): i18 - i26. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kjellstrand, U. Buoncristiani, G. Ting, J. Traeger, G. B. Piccoli, R. Sibai-Galland, B. A. Young, and C. R. Blagg Short daily haemodialysis: survival in 415 patients treated for 1006 patient-years Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3283 - 3289. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Lee, S. A. Zenios, and G. M. Chertow Cost-Effectiveness of Frequent In-Center Hemodialysis J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1792 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Punal, L. V. Lema, D. Sanhez-Guisande, and A. Ruano-Ravina Clinical effectiveness and quality of life of conventional haemodialysis versus short daily haemodialysis: a systematic review Nephrol. Dial. Transplant., August 1, 2008; 23(8): 2634 - 2646. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bodyak, J. C. Ayus, S. Achinger, V. Shivalingappa, Q. Ke, Y.-S. Chen, D. L. Rigor, I. Stillman, H. Tamez, P. E. Kroeger, et al. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals PNAS, October 23, 2007; 104(43): 16810 - 16815. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Culleton, M. Walsh, S. W. Klarenbach, G. Mortis, N. Scott-Douglas, R. R. Quinn, M. Tonelli, S. Donnelly, M. G. Friedrich, A. Kumar, et al. Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of Life: A Randomized Controlled Trial JAMA, September 19, 2007; 298(11): 1291 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Achinger and J. C. Ayus Left Ventricular Hypertrophy: Is Hyperphosphatemia among Dialysis Patients a Risk Factor? J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S255 - S261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. MacGregor, J. W. M. Agar, and C. R. Blagg Home haemodialysis--international trends and variation Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1934 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 5: Frequent and Sustained Hemodialysis J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S24 - S27. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673